Anthropic’s biolab made a discovery it’s comparing to Crispr
THE SO WHAT
If Claude can autonomously propose enzyme systems that biologists compare to CRISPR machinery, AI-assisted wet labs just moved from hype to pipeline. Biotech operators should assume model-guided discovery will compress early-stage timelines and rethink how they allocate human bench time versus compute.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIRingg’s AI agents resolve up to 65% of customer calls with OpenAI
If GPT-5.6 can handle 65% of calls across channels at 90% lower unit cost than GPT-4.1, the economics of front-line support are tilting from augmentation to replacement. CX leaders should be modeling what happens when the marginal cost of an incremental support interaction rounds toward zero and quality becomes the only real constraint.
Applied AIAmericans Are a Lot More Worried About AI Than the Rest of the World
Higher U.S. anxiety about AI is the cost of being the test market—users here are seeing both upside and failure modes first. If you’re building for global scale, expect more friction, scrutiny, and policy drag in the U.S. than in most other markets and plan your rollout and comms accordingly.
Applied AIThe Pope’s AI Guy Is Worried About ‘Cartel’ Behavior Among Big Labs
When a Vatican advisor starts talking about cartel dynamics in AI, the antitrust and governance conversation has clearly escaped the tech echo chamber. Large buyers should anticipate more scrutiny on exclusive deals and closed ecosystems and keep optionality in their model and infra choices.
Applied AIHow Customizable AI Models Are Enabling Hackers to Conduct Cybercrime Sprees
Customizable models give attackers the same leverage enterprises enjoy—automation, personalization, and scale—but with fewer guardrails. CISOs need to treat model abuse as a core threat vector and start red-teaming with AI-native tools, not just patching endpoints.